Vise Technologies, Inc.

Position in PTCT — Ptc Therapeutics, Inc.

CIK 1812090 NEW YORK, NY

Position in PTCT

as of Mar 31, 2026 · filed Apr 21, 2026 Compact

Position Value

$670,535

-$77,063 QoQ

Shares Held

9,842

0.0% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Vise Technologies, Inc. holds $12,234,017 across 26 Biotechnology names. PTCT ranks #4 (5.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	5,259	$2,348,353
2	REGN	Regeneron Pharmaceuticals, Inc.	1,402	$1,083,241
3	INSM	INSMED Inc	6,314	$1,032,465
4	PTCT	Ptc Therapeutics, Inc. This page	9,842	$670,535
5	RPRX	Royalty Pharma plc	10,651	$510,928
6	ALNY	Alnylam Pharmaceuticals, Inc.	1,515	$501,268
7	HALO	Halozyme Therapeutics, Inc.	7,424	$479,813
8	ARGX	Argenx SE	620	$452,755

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$670,535	9,842	0.0%	Shares	Sole	2026-04-21
2025-12-31	$747,598	9,842	+8.3%	Shares	Sole	2026-02-11
2025-09-30	$557,607	9,086	-8.6%	Shares	Sole	2025-11-13
2025-06-30	$485,518	9,941	-2.7%	Shares	Sole	2025-08-07
2024-12-31	$461,105	10,215	-6.2%	Shares	Sole	2025-02-18
2024-09-30	$403,907	10,887	-24.0%	Shares	Sole	2024-11-13
2024-06-30	$437,783	14,316	+8.9%	Shares	Sole	2024-08-02
2024-03-31	$382,475	13,148	+2.7%	Shares	Sole	2024-05-15
2023-12-31	$352,988	12,808	+20.1%	Shares	Sole	2024-02-08
2023-09-30	$239,069	10,668	+18.6%	Shares	Sole	2023-10-31
2023-06-30	$365,826	8,995	+5.6%	Shares	Sole	2023-08-08
2023-03-31	$412,805	8,522	+5.5%	Shares	Sole	2023-05-10
2022-12-31	$308,337	8,078	+19.3%	Shares	Sole	2023-02-10
2022-09-30	$339,954	6,772	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.